Clinical trial

Alendronate for Prevention of AntiRetroviral Therapy-associated Bone Loss

NCT02322099

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Alendronate Normalized identity: alendronateView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

DIETARY_SUPPLEMENT · Unmapped registry intervention calcium carbonate and colecalciferol Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Tenofovir disoproxil Normalized identity: tenofovir disoproxilView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Alendronate for Prevention of AntiRetroviral Therapy-associated Bone Loss

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2016-05-01

PhasePHASE4

Conditions

Bone Demineralizationunresolved

Interventions

AlendronateDRUG · verified · RxNorm: alendronate

PlaceboDRUG

calcium carbonate and colecalciferolDIETARY_SUPPLEMENT

Tenofovir disoproxilDRUG · verified · RxNorm: tenofovir disoproxil

Sponsors & collaborators

University College Dublinlead sponsor

Health Research Board, Irelandcollaborator

Royal College of Surgeons, Irelandcollaborator

Mater Misericordiae University Hospitalcollaborator

Beaumont Hospitalcollaborator

Rush University Medical Centercollaborator

Mapped research locations

DublinIreland2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02322099 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.